Immunosuppressive B cells expressing PD-1/PD-L1 in solid tumors: a mini review
- PMID: 31250021
- DOI: 10.1093/qjmed/hcz162
Immunosuppressive B cells expressing PD-1/PD-L1 in solid tumors: a mini review
Abstract
Expression of programmed cell death-1 (PD-1/CD279) on T cells and the ligand of PD-1, programmed death ligand-1 (PD-L1) (CD274/B7-H1) on tumor cells or other immune cells, such as myeloid-derived suppressor cells, are important mechanisms to induce malignant immunosuppression. PD-1/PD-L1 expression on B-cell subsets, as well as their signaling and inhibitory functions in solid tumors will be discussed in this review with the focus on how B cells expressing PD-1/PD-L1 play immunosuppressive roles in tumor progression, aiming to figure out the potential for development of diagnostic tools and new therapies involving this unique group of cells.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
[Research advances of myeloid-derived suppressor cells mediated by programmed death-1/programmed death-ligand 1 pathway in sepsis-induced immunosuppression].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Mar;36(3):332-336. doi: 10.3760/cma.j.cn121430-20231028-00918. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38538366 Review. Chinese.
-
PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL).Clin Neuropathol. 2014 Jan-Feb;33(1):42-9. doi: 10.5414/np300698. Clin Neuropathol. 2014. PMID: 24359606
-
PD-1 and PD-L1 expression on T-cell subsets in women with unexplained recurrent pregnancy losses.Am J Reprod Immunol. 2020 May;83(5):e13230. doi: 10.1111/aji.13230. Epub 2020 Mar 23. Am J Reprod Immunol. 2020. PMID: 32086851
-
Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?Clin Neuropathol. 2015 Nov-Dec;34(6):313-21. doi: 10.5414/np300922. Clin Neuropathol. 2015. PMID: 26501438 Free PMC article. Review.
-
The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1+ regulator B cells mediates immunosuppression in triple-negative breast cancer.Front Immunol. 2022 Jul 22;13:830606. doi: 10.3389/fimmu.2022.830606. eCollection 2022. Front Immunol. 2022. PMID: 35935985 Free PMC article.
Cited by
-
Complete and durable response of pulmonary large-cell neuroendocrine carcinoma to pembrolizumab.Cancer Rep (Hoboken). 2022 Aug;5(8):e1589. doi: 10.1002/cnr2.1589. Epub 2021 Nov 24. Cancer Rep (Hoboken). 2022. PMID: 34817132 Free PMC article.
-
PD-1 siRNA-Encapsulated Solid Lipid Nanoparticles Downregulate PD-1 Expression by Macrophages and Inhibit Tumor Growth : PD-1 siRNA-Encapsulated Solid Lipid Nanoparticles.AAPS PharmSciTech. 2021 Jan 31;22(2):60. doi: 10.1208/s12249-021-01933-y. AAPS PharmSciTech. 2021. PMID: 33517490 Free PMC article.
-
Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?Transl Oncol. 2020 Oct;13(10):100811. doi: 10.1016/j.tranon.2020.100811. Epub 2020 Jul 1. Transl Oncol. 2020. PMID: 32622310 Free PMC article. Review.
-
HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway.Elife. 2022 Oct 27;11:e79924. doi: 10.7554/eLife.79924. Elife. 2022. PMID: 36300787 Free PMC article.
-
The Evolving Landscape of B Cells in Cancer Metastasis.Cancer Res. 2023 Dec 1;83(23):3835-3845. doi: 10.1158/0008-5472.CAN-23-0620. Cancer Res. 2023. PMID: 37815800 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
